Clinical Trials Exempted | Regis Group Assists High-Risk Product Disposable Cerebrospinal Fluid Shunt and Accessories in Market Launch

In August 2024, an imported medical device declared by Integra LifeSciences (Shanghai) Co., Ltd.—the Disposable Cerebrospinal Fluid Shunt and Accessories—was officially approved for market launch. The Regis Group team provided clinical evaluation services for Integra, helping to accelerate the new product's entry into clinical application.